Cargando…

Is diagnosing patients with Organic Acidurias and Aminoacidopathies enough? Conundrums of a low middle-income country

OBJECTIVE: This study was done to determine the factors responsible for non-treatment of inherited metabolic disorders (IMDs) requiring food for special medical purposes (FSMPs) in Pakistan. METHODS: A descriptive cross-sectional study was conducted by Departments of Pediatrics & Child Health an...

Descripción completa

Detalles Bibliográficos
Autores principales: Majid, Hafsa, Jafri, Lena, Ali, Zeba Zulfiqar, Afroze, Bushra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613019/
https://www.ncbi.nlm.nih.gov/pubmed/34912414
http://dx.doi.org/10.12669/pjms.37.7.3887
_version_ 1784603549007609856
author Majid, Hafsa
Jafri, Lena
Ali, Zeba Zulfiqar
Afroze, Bushra
author_facet Majid, Hafsa
Jafri, Lena
Ali, Zeba Zulfiqar
Afroze, Bushra
author_sort Majid, Hafsa
collection PubMed
description OBJECTIVE: This study was done to determine the factors responsible for non-treatment of inherited metabolic disorders (IMDs) requiring food for special medical purposes (FSMPs) in Pakistan. METHODS: A descriptive cross-sectional study was conducted by Departments of Pediatrics & Child Health and Pathology & Laboratory Medicine, Aga Khan University. Patients diagnosed with IMDs from January 2013 to December 2016 requiring FSMPs were surveyed after a year of initial diagnosis to collect the details of treatment advised, mortality status, and reasons of non-treatment, including not prescribed by physician, non-acceptance by family, non-availability or non-affordability. RESULTS: Over four years period, 311 patients were identified with IMDs; Median age of patients was 1.0 yrs (0.0.2-3.65) with 54% (n=168) being male. Of the total 38.2% (n=119) required FSMPs, 9% (n=28) patients were excluded due to unavailability of diagnostics information. Parents of 58 patients requiring FSMPs out of 119 participated in survey. The leading causes of non-treatment were, FSMPs not prescribed by physicians (n= 30, 51.7%) followed by non-affordability (n=23, 39.6%), families’ unacceptance in (n=9, 18%) patients, non-availability of FSMPs (n=2, 3.4%) and early death of patient (n=1, 1.7%). CONCLUSION: The main factors responsible for non-treatment of FSMPs requiring IMDs were non-prescription by physician and non-affordability.
format Online
Article
Text
id pubmed-8613019
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Professional Medical Publications
record_format MEDLINE/PubMed
spelling pubmed-86130192021-12-14 Is diagnosing patients with Organic Acidurias and Aminoacidopathies enough? Conundrums of a low middle-income country Majid, Hafsa Jafri, Lena Ali, Zeba Zulfiqar Afroze, Bushra Pak J Med Sci Original Article OBJECTIVE: This study was done to determine the factors responsible for non-treatment of inherited metabolic disorders (IMDs) requiring food for special medical purposes (FSMPs) in Pakistan. METHODS: A descriptive cross-sectional study was conducted by Departments of Pediatrics & Child Health and Pathology & Laboratory Medicine, Aga Khan University. Patients diagnosed with IMDs from January 2013 to December 2016 requiring FSMPs were surveyed after a year of initial diagnosis to collect the details of treatment advised, mortality status, and reasons of non-treatment, including not prescribed by physician, non-acceptance by family, non-availability or non-affordability. RESULTS: Over four years period, 311 patients were identified with IMDs; Median age of patients was 1.0 yrs (0.0.2-3.65) with 54% (n=168) being male. Of the total 38.2% (n=119) required FSMPs, 9% (n=28) patients were excluded due to unavailability of diagnostics information. Parents of 58 patients requiring FSMPs out of 119 participated in survey. The leading causes of non-treatment were, FSMPs not prescribed by physicians (n= 30, 51.7%) followed by non-affordability (n=23, 39.6%), families’ unacceptance in (n=9, 18%) patients, non-availability of FSMPs (n=2, 3.4%) and early death of patient (n=1, 1.7%). CONCLUSION: The main factors responsible for non-treatment of FSMPs requiring IMDs were non-prescription by physician and non-affordability. Professional Medical Publications 2021 /pmc/articles/PMC8613019/ /pubmed/34912414 http://dx.doi.org/10.12669/pjms.37.7.3887 Text en Copyright: © Pakistan Journal of Medical Sciences https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0 (https://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Majid, Hafsa
Jafri, Lena
Ali, Zeba Zulfiqar
Afroze, Bushra
Is diagnosing patients with Organic Acidurias and Aminoacidopathies enough? Conundrums of a low middle-income country
title Is diagnosing patients with Organic Acidurias and Aminoacidopathies enough? Conundrums of a low middle-income country
title_full Is diagnosing patients with Organic Acidurias and Aminoacidopathies enough? Conundrums of a low middle-income country
title_fullStr Is diagnosing patients with Organic Acidurias and Aminoacidopathies enough? Conundrums of a low middle-income country
title_full_unstemmed Is diagnosing patients with Organic Acidurias and Aminoacidopathies enough? Conundrums of a low middle-income country
title_short Is diagnosing patients with Organic Acidurias and Aminoacidopathies enough? Conundrums of a low middle-income country
title_sort is diagnosing patients with organic acidurias and aminoacidopathies enough? conundrums of a low middle-income country
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613019/
https://www.ncbi.nlm.nih.gov/pubmed/34912414
http://dx.doi.org/10.12669/pjms.37.7.3887
work_keys_str_mv AT majidhafsa isdiagnosingpatientswithorganicaciduriasandaminoacidopathiesenoughconundrumsofalowmiddleincomecountry
AT jafrilena isdiagnosingpatientswithorganicaciduriasandaminoacidopathiesenoughconundrumsofalowmiddleincomecountry
AT alizebazulfiqar isdiagnosingpatientswithorganicaciduriasandaminoacidopathiesenoughconundrumsofalowmiddleincomecountry
AT afrozebushra isdiagnosingpatientswithorganicaciduriasandaminoacidopathiesenoughconundrumsofalowmiddleincomecountry